ArticleTranslational oncology2026

Multi-omics and experimental validation identify RAPGEF2 as a protective prognostic biomarker in clear cell renal cell carcinoma.

Yanfei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.